Overall Status

Recruiting (11)

Completed (7)

Unknown status (5)

Terminated (3)

Active, not recruiting (2)

Withdrawn (1)

Phase

phase 2 (10)

phase 1 (4)

phase 4 (3)

phase 3 (2)

n/a (1)

phase 2/phase 3 (1)

Study Documents

Intervention Type

drug (21)

other (3)

procedure (2)

Funder Type

Other (25)

Industry (4)

Study Type

Interventional (21)

Observational (7)

Observational [Patient Registry] (1)

Acute Promyelocytic Leukemia

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Promyelocytic Leukemia Trial in Chicago (Tamibarotene, Arsenic trioxide)

Terminated

Acute Promyelocytic Leukemia

Tamibarotene
Arsenic trioxide

Chicago, Illinois

Northwestern University

Oct 28, 2013

Acute Promyelocytic Leukemia Trial in Chicago, Houston (Tamibarotene)

Completed

Acute Promyelocytic Leukemia

Tamibarotene

Chicago, Illinois
+1 more

Feb 11, 2013

Acute Promyelocytic Leukemia Trial in Santa Monica, (NRX 195183 Soft Gelatin Capsule)

Unknown status

Acute Promyelocytic Leukemia

NRX 195183 Soft Gelatin Capsule

Santa Monica,, California

Sarcoma Oncology Center

May 9, 2008

Acute Promyelocytic Leukemia Trial in India (Single agent arsenic trioxide)

Unknown status

Acute Promyelocytic Leukemia

Single agent arsenic trioxide

Bangalore, Karnataka, India
+8 more

Aug 16, 2007